International Market Briefing

Monday, July 27, 2026 | 7:30 a.m.
Location: Anaheim Marriott (Marquis Ballroom) – Anaheim, CA, USA

Held in conjunction with ADLM 2026 (formerly AACC Annual Meeting & Clinical Lab Expo)

Register Now

Registration

Registration for ADLM 2026 is required to attend the International Market Briefing (IMB). The IMB is a ticketed special event, but there is no additional cost to attend.

• During registration, add the International Market Briefing (IMB) under ticketed sessions.
• Select Conference Registration to access education sessions, the Clinical Lab Expo, and the IMB.
• Select Clinical Lab Expo if attending only the IMB and Expo.
• Already registered? Add the IMB through the Registration Resource Center.

Advance registration is required by Sunday, July 26. Attendees must obtain their official event badge in advance to gain entry.

If you have questions, please contact ADLM Customer Service at [email protected].

Learn about global IVD market trends

Join ADLM for the 2026 International Market Briefing & Financial Analyst Briefing, where global leaders in diagnostics explore trends shaping the IVD market.

• Gain insights into key IVD market sectors and emerging trends
• Explore developments across global and emerging markets
• Connect and network with industry peers

Who should attend

This program is intended for international marketing executives, financial analysts, trade specialists, distributors, and others responsible for international marketing and sales.

Register Now

Program agenda

Monday, July 27, 2026 – Anaheim, CA, USA

7:30 – 8:15 a.m. | Networking Breakfast

8:15 – 8:20 a.m. | ADLM CEO Welcome & Opening Remarks

Melanie J. Wells, MPH, CAE
ADLM CEO

8:20 – 8:30 a.m. | ADLM Board President Welcome

Paul J. Jannetto, Ph.D., DABCC, FACB, M.T.(ASCP)
ADLM Board President

8:30 – 8:40 a.m. | Speaker Introductions

Kristin Pothier
Life Sciences Sector Leader, Global Deal Advisory and Strategy Leader, KPMG

8:40 – 9:25 a.m. | Global IVD Market Update – IQVIA

David Kowalski
Principal – Global Head of IVD Consulting, IQVIA MedTech IVD Solutions

9:25 – 10:15 a.m. | Expanding Access in Diagnostics: The Evolving Role of Testing Across Settings

Diagnostic testing is expanding beyond the traditional lab into near-patient and home-based settings.

Panelist: Rebecca Ewald, PhD
Vice President/Lifecycle Leader, Oncology Assays
Roche Diagnostics

Panelist: Dr. Dirk Kuhlmeier
Co-Founder & CTO, Intu Diagnostics
Fraunhofer Institute for Cell Therapy and Immunology IZI

Panelist: Vanessa Lagona
Marketing Manager, Preventis

Panelist: Steve H. Wong, Ph.D.
Professor Emeritus of Pathology
Wake Forest University School of Medicine

Moderator: Mark Whitten, PhD
Managing Director, TriMar Strategies

10:15 – 10:30 a.m. | Networking Break

10:30 – 11:15 a.m. | AI in Diagnostics: Enhancing Testing & Workflow Performance

Panelist: Nicholas (Nick) Spies, MD
Medical Director in Applied AI and Clinical Chemistry
ARUP Laboratories

Panelist: Mark Zaydman, MD, PhD
Associate Professor of Pathology and Immunology
Washington University School of Medicine in St. Louis

Panelist: Prashant Prabudh
Director, Analytics and Data Science
Clinisys

Panelist: Paavana Sainath
SVP, Head of R&D-Engineering, Core Lab Solutions
Siemens Healthineers

Moderator: Sarah Wheeler, PhD
Director, Laboratory Medicine AI, Computational Pathology & AI Center of Excellence
University of Pittsburgh

11:15 – 11:45 a.m. | M&A Trends in IVD and Lab Testing

Jessica Lin
Partner, KPMG

 Anil Asnani
Vice President, Strategic Planning and Corporate Development
LabCorp

11:45 a.m. – 12:00 p.m. | Closing Remarks

Kristin Pothier
Life Sciences Sector Leader, KPMG